Petros Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Petros Pharmaceuticals, Inc. (PTPI) had Shares Outstanding (Cover Page) of 42.37 million shares as of 2026-08-15, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-15: Entity Common Stock, Shares Outstanding 42.37M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 42.37M shares.
- 2026-04-15: Entity Common Stock, Shares Outstanding 42.37M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 42.37M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-15 | 42.37M shares 10-Q · filed 2026-08-13 |
| 2026-05-12 | 42.37M shares 10-Q · filed 2026-05-13 |
| 2026-04-15 | 42.37M shares 10-K · filed 2026-04-15 |
| 2025-11-12 | 42.37M shares 10-Q · filed 2025-11-13 |
| 2025-08-13 | 42.37M shares 10-Q · filed 2025-08-14 |
| 2025-05-14 | 31.16M shares 10-Q · filed 2025-05-15 |
| 2025-03-27 | 53.52M shares 10-K · filed 2025-03-31 |
| 2024-11-12 | 10.01M shares 10-Q · filed 2024-11-13 |
| 2024-08-13 | 9.61M shares 10-Q · filed 2024-08-14 |
| 2024-05-30 | 7.00M shares 10-K/A · filed 2024-05-31 |
| 2024-05-13 | 7.00M shares 10-Q · filed 2024-05-15 |
| 2024-03-26 | 6.88M shares 10-K · filed 2024-04-01 |
| 2023-11-14 | 2.20M shares 10-Q · filed 2023-11-15 |
| 2023-08-14 | 2.11M shares 10-Q · filed 2023-08-14 |
| 2023-05-15 | 2.11M shares 10-Q · filed 2023-05-15 |
| 2023-03-31 | 2.09M shares 10-K · filed 2023-03-31 |
| 2022-11-14 | 20.71M shares 10-Q/A · filed 2022-11-15 |
| 2022-08-10 | 20.68M shares 10-Q · filed 2022-08-12 |
| 2022-05-13 | 20.68M shares 10-Q · filed 2022-05-16 |
| 2022-03-31 | 20.68M shares 10-K · filed 2022-03-31 |
| 2021-11-11 | 13.15M shares 10-Q · filed 2021-11-15 |
| 2021-08-09 | 9.83M shares 10-Q · filed 2021-08-16 |
| 2021-05-10 | 9.80M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |